RUNX2 was significantly decreased by transfection of a miRNA-218 mimic, and RUNX2 expression was obviously increased by treatment with a miRNA-218 inhibitor in osteosarcoma U2OS cells [20]. This evidence concerns the gene RUNX2 and osteosarcoma.